AlphaCyte

AlphaCyte is an investigational **allogeneic human umbilical cord-derived mesenchymal stem cell** product being developed by Alpha Health Life Scientific. It is a cell therapy based on hUC-MSCs and is described as a clinical-grade investigational cell drug with active IND clearance referenced by the company. Its therapeutic rationale is not based on a single molecular target; rather, the product is intended to act through canonical mesenchymal stem cell mechanisms including immunomodulation, paracrine trophic signaling, exosome-mediated effects, mitochondrial transfer, angiogenesis support, and multilineage regenerative activity. Publicly available company materials do not clearly define a formal lead indication, although they suggest potential relevance to diabetes and metabolic disease settings.

Brand names

AlphaCyte

Other names

allogeneic human umbilical cord-derived mesenchymal stem cellshUC-MSChuman umbilical cord-derived mesenchymal stem cells